SOMERSET, N.J., Oct. 07, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (“CareCloud” or the “Company”) (Nasdaq: CCLD, CCLDO), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, announced today that its Board of Directors (the “Board”) has declared monthly cash dividends for its 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock (“Series A Preferred Stock”) and its 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock (“Series B P ...

Core Insights - CareCloud, Inc. will release its financial results for the second quarter ended June 30, 2025, before the market opens on August 5, 2025 [1] - A conference call for investors will follow at 8:30 a.m. Eastern Time on the same day [1] Company Overview - CareCloud is a leader in AI-powered healthcare technology and revenue cycle management solutions, serving medical practices and health systems across the nation [1] - The company offers a suite of solutions aimed at improving financial and operational performance, streamlining clinical workflows, and enhancing patient experience [4] - More than 40,000 providers rely on CareCloud to improve patient care while reducing administrative burdens and operating costs [4]

Core Insights - CareCloud, Inc. has been added to the Russell Microcap® Index, effective June 30, 2025, highlighting its growing recognition in the healthcare technology sector [1][3] - The company's common stock price increased by approximately 70% during Q2 2025, driven by key developments including the launch of an AI Center of Excellence and a strong cash position of around $10 million [2] Company Developments - The launch of CareCloud's AI Center of Excellence is a significant milestone aimed at enhancing its technological capabilities [2] - The company resumed acquisition activities in targeted growth areas, indicating a strategic focus on expansion [2] - Approximately 3.5 million shares of Series A Preferred Stock were converted into Common Stock on March 6, 2025, reflecting a shift in capital structure [2] Financial Performance - CareCloud reported a strong cash position of approximately $10 million at the end of Q2 2025, which supports its operational and strategic initiatives [2] - The inclusion in the Russell Microcap Index serves as a benchmark for performance in the U.S. small-cap equity market, potentially attracting more institutional investors [3]

Core Insights - CareCloud, Inc. has launched its AI Center of Excellence (AI CoE), aimed at delivering scalable, domain-specific AI solutions for healthcare [1][2] - The AI CoE began operations with a team of over 50 professionals and plans to expand to 500 by Q4 2025, positioning itself as the largest dedicated healthcare AI initiative globally [2][3] - The initiative is fully self-funded, showcasing CareCloud's strong cash flows and efficient cost structure, which allows for accelerated innovation and cost-effective solutions [2][4] Company Strategy - The AI CoE is a pivotal part of CareCloud's growth strategy, emphasizing the need for innovation in the healthcare sector to remain competitive [3][5] - CareCloud aims to integrate AI across its technology stack, enhancing operational efficiency and clinical outcomes while reducing administrative burdens [4][5] - The company is focused on developing proprietary healthcare AI models, streamlining clinical workflows, and improving patient engagement through AI-driven personalization [7] Industry Impact - The healthcare industry is rapidly adopting AI, and CareCloud's AI CoE is positioned to lead this transformation by driving operational changes and improving care delivery [5][6] - By leveraging 25 years of clinical and financial data, CareCloud is developing AI solutions that are compliant with HIPAA regulations, ensuring immediate real-world impact [2][4] - The focus on predictive analytics will enable earlier identification of reimbursement risks and operational bottlenecks, further enhancing the efficiency of healthcare providers [7]